{
    "hands_on_practices": [
        {
            "introduction": "The initial evaluation of a patient with gastric outlet obstruction (GOO) extends beyond imaging to a critical assessment of their metabolic state. The characteristic loss of hydrochloric acid through vomiting creates a classic hypochloremic metabolic alkalosis, but the accompanying hypovolemia and starvation can introduce confounding factors. This first practice problem challenges you to apply the fundamental principle of electroneutrality to interpret a patient's electrolyte panel, calculate the anion gap, and uncover a potential mixed acid-base disorder . Mastering this analysis is essential for guiding appropriate and safe initial resuscitation.",
            "id": "5125632",
            "problem": "A patient with suspected gastric outlet obstruction (GOO) presents with several days of nonbilious vomiting, hypovolemia, and metabolic derangements. The principle of electroneutrality requires that, within any compartment, the algebraic sum of charges is zero, so the sum of concentrations of major measured cations equals the sum of concentrations of major measured anions plus the contribution of unmeasured anions. In the extracellular fluid, the dominant measured cation is sodium $[\\mathrm{Na}^+]$, and the dominant measured anions are chloride $[\\mathrm{Cl}^-]$ and bicarbonate $[\\mathrm{HCO}_3^-]$. The anion gap is defined as the difference between the concentration of measured cations and the concentration of measured anions, representing the net contribution of unmeasured anions. Assume serum albumin is $4.0$ g/dL.\n\nYou are given the following serum values: $[\\mathrm{Na}^+] = 138$ mEq/L, $[\\mathrm{Cl}^-] = 82$ mEq/L, and $[\\mathrm{HCO}_3^-] = 40$ mEq/L.\n\nUsing first principles of charge balance, derive the expression for the anion gap in terms of the given measured ions, compute its value for this patient, and, based on physiologic reasoning about hydrogen chloride loss in gastric outlet obstruction and the provided laboratory profile, interpret the primary acid–base disorder. Provide only the numerical value of the anion gap as your final answer. Round your numerical result to four significant figures and express the anion gap in milliequivalents per liter (mEq/L).",
            "solution": "### Solution Derivation and Interpretation\n\nThe principle of electroneutrality states that the total concentration of positive charges (cations) must equal the total concentration of negative charges (anions) in any given fluid compartment. For plasma, this can be expressed as:\n$$\n\\sum [\\text{Cations}] = \\sum [\\text{Anions}]\n$$\nWe can partition both cations and anions into measured and unmeasured components:\n$$\n[\\text{Measured Cations}] + [\\text{Unmeasured Cations}] = [\\text{Measured Anions}] + [\\text{Unmeasured Anions}]\n$$\nThe problem defines the anion gap (AG) as the difference between the measured cations and measured anions. This difference, therefore, must be equal to the concentration of unmeasured anions (UA) minus the concentration of unmeasured cations (UC).\n$$\n\\text{AG} = [\\text{Measured Cations}] - [\\text{Measured Anions}] = [\\text{Unmeasured Anions}] - [\\text{Unmeasured Cations}]\n$$\nIn clinical chemistry, the unmeasured anions (e.g., albumin, phosphates, sulfates, organic acids) significantly exceed the unmeasured cations (e.g., potassium, calcium, magnesium). Thus, the anion gap provides an estimate of the net concentration of unmeasured anions.\n\nAccording to the problem statement, the major measured cation is $[\\mathrm{Na}^+]$ and the major measured anions are $[\\mathrm{Cl}^-]$ and $[\\mathrm{HCO}_3^-]$. Substituting these into the definition of the anion gap yields the required expression:\n$$\n\\text{AG} = [\\mathrm{Na}^+] - ([\\mathrm{Cl}^-] + [\\mathrm{HCO}_3^-])\n$$\nNow, we compute the value of the anion gap for the patient using the provided laboratory data:\n- $[\\mathrm{Na}^+] = 138 \\text{ mEq/L}$\n- $[\\mathrm{Cl}^-] = 82 \\text{ mEq/L}$\n- $[\\mathrm{HCO}_3^-] = 40 \\text{ mEq/L}$\n\nSubstituting these values into the derived expression:\n$$\n\\text{AG} = 138 - (82 + 40)\n$$\n$$\n\\text{AG} = 138 - 122\n$$\n$$\n\\text{AG} = 16 \\text{ mEq/L}\n$$\nThe problem requires the result to be rounded to four significant figures.\n$$\n\\text{AG} = 16.00 \\text{ mEq/L}\n$$\nFinally, we interpret the acid-base disorder. The patient's history of vomiting due to gastric outlet obstruction leads to the loss of large volumes of gastric fluid, which is rich in hydrochloric acid ($\\mathrm{HCl}$).\n1.  The loss of hydrogen ions ($\\mathrm{H}^+$) causes a systemic increase in bicarbonate ($\\mathrm{HCO}_3^-$) as the kidneys work to maintain charge balance, leading to a metabolic alkalosis. The a high serum bicarbonate of $40$ mEq/L (normal range approx. $22-28$ mEq/L) confirms this.\n2.  The loss of chloride ions ($\\mathrm{Cl}^-$) leads to hypochloremia. The low serum chloride of $82$ mEq/L (normal range approx. $98-106$ mEq/L) is consistent with this.\n3.  Therefore, the primary acid-base disorder is a **hypochloremic metabolic alkalosis**.\n\nThe calculated anion gap is $16.00$ mEq/L. A normal anion gap is typically in the range of $8-12$ mEq/L. This patient's anion gap is elevated. An elevated anion gap typically signifies the presence of an anion gap metabolic acidosis, caused by the accumulation of unmeasured anions. In this clinical context, the hypovolemia can cause poor tissue perfusion and subsequent lactic acidosis. Additionally, starvation resulting from the gastric obstruction can lead to ketoacidosis. Both lactate and keto-acids are unmeasured anions. Therefore, the complete picture is a primary metabolic alkalosis with a superimposed high anion gap metabolic acidosis.",
            "answer": "$$\n\\boxed{16.00}\n$$"
        },
        {
            "introduction": "Once the complex metabolic alkalosis of GOO is identified, the next step is targeted fluid resuscitation to correct the chloride deficit and normalize pH. The choice of crystalloid is not arbitrary; different solutions have vastly different impacts on the body's acid-base balance. This exercise uses the principle of mass conservation to quantify the effectiveness of different fluids in chloride repletion, providing a concrete, mathematical basis for a critical clinical decision . By solving this, you will gain a deeper understanding of how fluid selection directly manipulates the strong ion difference to resolve metabolic disturbances.",
            "id": "5125660",
            "problem": "A $70$ kg patient with gastric outlet obstruction from chronic pyloric stenosis presents with hypovolemia and hypochloremic, hypokalemic metabolic alkalosis after several days of nonbilious vomiting. On admission, arterial blood gas shows a pH consistent with metabolic alkalosis and serum electrolytes are $[\\mathrm{Na}^{+}] = 140$ mEq/L and $[\\mathrm{Cl}^{-}] = 78$ mEq/L. Assume the extracellular fluid (ECF) volume is initially $0.20 \\times$ body weight and that the infused fluid distributes only within the ECF with instantaneous mixing, there are no ongoing gastrointestinal or renal losses, and the partial pressure of carbon dioxide (pCO$_{2}$) and total concentration of weak acids remain approximately constant over the time frame considered.\n\nYou plan to correct the chloride deficit to restore $[\\mathrm{Cl}^{-}]$ to a target of $102$ mEq/L using crystalloid infusion. Consider two options:\n- $0.9\\%$ sodium chloride (normal saline) with $[\\mathrm{Cl}^{-}] = 154$ mEq/L.\n- Lactated Ringer’s (a balanced crystalloid) with $[\\mathrm{Cl}^{-}] = 109$ mEq/L; the lactate anion is metabolized, so its net effect on chloride delivery is nil.\n\nUsing conservation of mass for chloride within the ECF and the definition of strong ion difference (SID) to reason about acid–base effects, derive the relation needed to determine the infusion volume required to achieve the target $[\\mathrm{Cl}^{-}]$, and compute the ratio of volumes $V_{\\mathrm{LR}}/V_{\\mathrm{NS}}$ required for Lactated Ringer’s versus normal saline to reach the same target $[\\mathrm{Cl}^{-}]$ under the stated assumptions. Express your final answer as a dimensionless number and round to three significant figures.",
            "solution": "The core principle for solving this problem is the conservation of mass, specifically for chloride ions ($\\mathrm{Cl}^{-}$), within the patient's extracellular fluid (ECF). We can state this principle with a mass balance equation: the final total amount of chloride in the ECF must equal the initial amount plus the amount added through infusion.\n\nLet us define the variables:\n- $V_{\\text{ECF},0}$ is the initial volume of the ECF.\n- $V_{\\text{inf}}$ is the volume of the infused crystalloid fluid.\n- $V_{\\text{ECF},f}$ is the final volume of the ECF after infusion.\n- $[\\mathrm{Cl}^{-}]_0$ is the initial concentration of chloride in the ECF.\n- $[\\mathrm{Cl}^{-}]_f$ is the final (target) concentration of chloride in the ECF.\n- $[\\mathrm{Cl}^{-}]_{\\text{inf}}$ is the concentration of chloride in the infused fluid.\n\nThe total amount of a substance in a volume is the product of its concentration and the volume. The mass balance equation for chloride is therefore:\n$$[\\mathrm{Cl}^{-}]_f \\times V_{\\text{ECF},f} = [\\mathrm{Cl}^{-}]_0 \\times V_{\\text{ECF},0} + [\\mathrm{Cl}^{-}]_{\\text{inf}} \\times V_{\\text{inf}}$$\nThe problem states that the infused volume is added to the ECF, so the final ECF volume is the sum of the initial and infused volumes:\n$$V_{\\text{ECF},f} = V_{\\text{ECF},0} + V_{\\text{inf}}$$\nSubstituting this expression for $V_{\\text{ECF},f}$ into the mass balance equation gives:\n$$[\\mathrm{Cl}^{-}]_f \\times (V_{\\text{ECF},0} + V_{\\text{inf}}) = [\\mathrm{Cl}^{-}]_0 \\times V_{\\text{ECF},0} + [\\mathrm{Cl}^{-}]_{\\text{inf}} \\times V_{\\text{inf}}$$\nThis equation represents the general relation required to determine the infusion volume. To make it more explicit, we can solve for $V_{\\text{inf}}$:\n$$[\\mathrm{Cl}^{-}]_f V_{\\text{ECF},0} + [\\mathrm{Cl}^{-}]_f V_{\\text{inf}} = [\\mathrm{Cl}^{-}]_0 V_{\\text{ECF},0} + [\\mathrm{Cl}^{-}]_{\\text{inf}} V_{\\text{inf}}$$\nRearranging the terms to isolate $V_{\\text{inf}}$:\n$$V_{\\text{inf}} ([\\mathrm{Cl}^{-}]_{\\text{inf}} - [\\mathrm{Cl}^{-}]_f) = V_{\\text{ECF},0} ([\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0)$$\n$$V_{\\text{inf}} = V_{\\text{ECF},0} \\frac{[\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0}{[\\mathrm{Cl}^{-}]_{\\text{inf}} - [\\mathrm{Cl}^{-}]_f}$$\nThis derived relation allows calculation of the required infusion volume to reach a target chloride concentration.\n\nThe context of this correction is the patient's metabolic alkalosis. According to the Stewart model of acid-base physiology, this alkalosis is caused by an elevated Strong Ion Difference (SID), which is the difference between the concentrations of strong cations and strong anions. For this patient, the key contributors are $[\\mathrm{Na}^{+}]$ and $[\\mathrm{Cl}^{-}]$. The initial apparent SID is $\\text{SID}_{\\text{app},0} = [\\mathrm{Na}^{+}]_0 - [\\mathrm{Cl}^{-}]_0 = 140 \\, \\text{mEq/L} - 78 \\, \\text{mEq/L} = 62 \\, \\text{mEq/L}$. This high SID (normal is approximately $40 \\, \\text{mEq/L}$) drives the metabolic alkalosis. By infusing a chloride-containing solution, we increase $[\\mathrm{Cl}^{-}]$ and thus lower the SID, correcting the acid-base disturbance. The choice of fluid affects the efficiency of this correction.\n\nWe are asked to compute the ratio of the volumes required for Lactated Ringer’s ($V_{\\text{LR}}$) versus normal saline ($V_{\\text{NS}}$) to achieve the same target $[\\mathrm{Cl}^{-}]_f$.\n\nLet $V_{\\text{NS}}$ be the required volume of normal saline. The chloride concentration in normal saline is $[\\mathrm{Cl}^{-}]_{\\text{NS}} = 154 \\, \\text{mEq/L}$. Using our derived formula:\n$$V_{\\text{NS}} = V_{\\text{ECF},0} \\frac{[\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0}{[\\mathrm{Cl}^{-}]_{\\text{NS}} - [\\mathrm{Cl}^{-}]_f}$$\nLet $V_{\\text{LR}}$ be the required volume of Lactated Ringer’s. The chloride concentration in Lactated Ringer's is $[\\mathrm{Cl}^{-}]_{\\text{LR}} = 109 \\, \\text{mEq/L}$. The formula gives:\n$$V_{\\text{LR}} = V_{\\text{ECF},0} \\frac{[\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0}{[\\mathrm{Cl}^{-}]_{\\text{LR}} - [\\mathrm{Cl}^{-}]_f}$$\nWe need to find the ratio $V_{\\text{LR}} / V_{\\text{NS}}$:\n$$\\frac{V_{\\text{LR}}}{V_{\\text{NS}}} = \\frac{V_{\\text{ECF},0} \\frac{[\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0}{[\\mathrm{Cl}^{-}]_{\\text{LR}} - [\\mathrm{Cl}^{-}]_f}}{V_{\\text{ECF},0} \\frac{[\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0}{[\\mathrm{Cl}^{-}]_{\\text{NS}} - [\\mathrm{Cl}^{-}]_f}}$$\nThe terms $V_{\\text{ECF},0}$ and $([\\mathrm{Cl}^{-}]_f - [\\mathrm{Cl}^{-}]_0)$ cancel, yielding a simplified expression for the ratio:\n$$\\frac{V_{\\text{LR}}}{V_{\\text{NS}}} = \\frac{[\\mathrm{Cl}^{-}]_{\\text{NS}} - [\\mathrm{Cl}^{-}]_f}{[\\mathrm{Cl}^{-}]_{\\text{LR}} - [\\mathrm{Cl}^{-}]_f}$$\nThis result shows that the ratio of required volumes depends only on the chloride concentrations of the two infusates and the target chloride concentration, not on the patient's initial state.\n\nNow, we substitute the given numerical values into this expression:\n- Target chloride concentration: $[\\mathrm{Cl}^{-}]_f = 102 \\, \\text{mEq/L}$\n- Normal saline chloride concentration: $[\\mathrm{Cl}^{-}]_{\\text{NS}} = 154 \\, \\text{mEq/L}$\n- Lactated Ringer’s chloride concentration: $[\\mathrm{Cl}^{-}]_{\\text{LR}} = 109 \\, \\text{mEq/L}$\n\n$$\\frac{V_{\\text{LR}}}{V_{\\text{NS}}} = \\frac{154 - 102}{109 - 102} = \\frac{52}{7}$$\nCalculating the numerical value of this fraction:\n$$\\frac{52}{7} \\approx 7.428571...$$\nRounding to three significant figures as requested, we obtain the final answer.\n$$\\frac{V_{\\text{LR}}}{V_{\\text{NS}}} \\approx 7.43$$\nThis result indicates that, under the specified model and assumptions, approximately $7.43$ times more volume of Lactated Ringer's is required compared to normal saline to achieve the same increase in serum chloride concentration. This is because the chloride concentration of Lactated Ringer's ($109 \\, \\text{mEq/L}$) is much closer to the target concentration ($102 \\, \\text{mEq/L}$) than that of normal saline ($154 \\, \\text{mEq/L}$), making it a less efficient fluid for this specific purpose of chloride repletion. The denominator in the volume equation, $([\\mathrm{Cl}^{-}]_{\\text{inf}} - [\\mathrm{Cl}^{-}]_f)$, becomes small, leading to a large required volume.",
            "answer": "$$\n\\boxed{7.43}\n$$"
        },
        {
            "introduction": "For patients with malignant GOO, the goal of treatment shifts from cure to palliation, prioritizing quality of life. The choice between endoscopic stenting and surgical bypass is a classic dilemma, pitting a less invasive procedure with potential for re-occlusion against a more durable but morbid operation. This final problem guides you through a formal decision analysis, using the concept of Quality-Adjusted Life Months (QALMs) to compare these strategies . By modeling probabilities of complications, reinterventions, and survival, this practice provides a powerful framework for making evidence-based, patient-centered recommendations in complex palliative scenarios.",
            "id": "5125653",
            "problem": "A patient with malignant gastric outlet obstruction (GOO) due to unresectable periampullary carcinoma requires palliation. Two strategies are under consideration: endoscopic placement of a self-expandable metal stent (SEMS) and surgical gastrojejunostomy bypass (GJ). The expected patient survival time is modeled as exponentially distributed with rate parameter $\\lambda$, so the survival function is $S(t) = \\exp(-\\lambda t)$. Quality-adjusted life months (QALMs) are defined as the expected value of the time integral of a utility rate $u(t)$, weighted by survival, where the utility rate reflects the quality of oral intake and global well-being under each strategy. Assume independence of early complications and subsequent reinterventions.\n\nUse the following scientifically plausible parameters for malignant GOO:\n- Survival rate: $\\lambda = \\frac{\\ln(2)}{5}$ per month (median survival $5$ months).\n- SEMS baseline utility while patent: $u_{S}^{\\text{base}} = 0.8$.\n- SEMS early major complication probability: $p_{S} = 0.15$, with utility $u_{S}^{\\text{comp}} = 0.3$ lasting $\\delta_{S} = 0.5$ months from time $t=0$ before returning to $u_{S}^{\\text{base}}$ thereafter.\n- SEMS reintervention probability: $q_{S} = 0.4$, occurring at $t_{S} = 2.5$ months if still alive, with a downtime of $d_{S} = 0.25$ months during which utility is $u_{S}^{\\text{down}} = 0.2$, returning to $u_{S}^{\\text{base}}$ after downtime.\n- GJ baseline utility while patent: $u_{B}^{\\text{base}} = 0.75$.\n- GJ early major complication probability: $p_{B} = 0.25$, with utility $u_{B}^{\\text{comp}} = 0.2$ lasting $\\delta_{B} = 1.0$ months from time $t=0$ before returning to $u_{B}^{\\text{base}}$ thereafter.\n- GJ reintervention probability: $q_{B} = 0.1$, occurring at $t_{B} = 4.0$ months if still alive, with a downtime of $d_{B} = 0.5$ months during which utility is $u_{B}^{\\text{down}} = 0.2$, returning to $u_{B}^{\\text{base}}$ after downtime.\n\nStarting strictly from the definitions of expected value and the exponential survival function $S(t)$, construct the decision tree for each strategy and derive the expected QALMs for SEMS and for GJ by integrating the survival-weighted utility over time, accounting for the probability-weighted periods of reduced utility for early complications and reinterventions. Then compute the expected utility difference $\\Delta U = U_{\\text{SEMS}} - U_{\\text{GJ}}$.\n\nRound your final numeric answer for $\\Delta U$ to four significant figures. Express the final answer in quality-adjusted life months (QALMs).",
            "solution": "The fundamental base is the definition of expected value and the survival function for an exponential distribution. The expected quality-adjusted life months (QALMs) under a time-varying utility rate $u(t)$ with survival function $S(t)$ is\n$$\nU = \\mathbb{E}\\left[\\int_{0}^{\\infty} u(t) \\mathbf{1}_{\\{Tt\\}} \\, dt \\right] = \\int_{0}^{\\infty} u(t) S(t) \\, dt,\n$$\nwhere $T$ is the random survival time. For exponential survival with rate $\\lambda$, $S(t) = \\exp(-\\lambda t)$.\n\nWe model each strategy’s utility trajectory as a baseline utility $u^{\\text{base}}$ punctuated by possible periods of reduced utility due to early complications and reinterventions. By linearity of expectation and independence assumptions, we can start from the baseline integral and add probability-weighted corrections for the intervals in which utility deviates from baseline.\n\nFor a given strategy $X \\in \\{\\text{SEMS}, \\text{GJ}\\}$, define:\n- Baseline utility $u_{X}^{\\text{base}}$.\n- Early complication probability $p_{X}$ with utility $u_{X}^{\\text{comp}}$ for duration $\\delta_{X}$ starting at $t=0$, then returning to $u_{X}^{\\text{base}}$.\n- Reintervention probability $q_{X}$ at time $t_{X}$ if alive, creating a downtime of duration $d_{X}$ with utility $u_{X}^{\\text{down}}$, then returning to $u_{X}^{\\text{base}}$.\n\nThe baseline expected QALMs (if no events ever occurred) would be\n$$\nU_{X}^{\\text{baseline}} = \\int_{0}^{\\infty} u_{X}^{\\text{base}} \\exp(-\\lambda t) \\, dt = \\frac{u_{X}^{\\text{base}}}{\\lambda}.\n$$\nTwo adjustments are needed:\n1. Early complication interval $[0,\\delta_{X}]$ replaces $u_{X}^{\\text{base}}$ with $u_{X}^{\\text{comp}}$ with probability $p_{X}$. Its expected contribution relative to baseline is\n$$\np_{X} \\int_{0}^{\\delta_{X}} \\left(u_{X}^{\\text{comp}} - u_{X}^{\\text{base}}\\right) \\exp(-\\lambda t) \\, dt = p_{X} \\left(u_{X}^{\\text{comp}} - u_{X}^{\\text{base}}\\right) \\frac{1 - \\exp(-\\lambda \\delta_{X})}{\\lambda}.\n$$\n2. Reintervention interval $[t_{X}, t_{X}+d_{X}]$ replaces $u_{X}^{\\text{base}}$ with $u_{X}^{\\text{down}}$ with probability $q_{X}$. Because the survival weighting already accounts for whether the patient is alive at those times, the expected contribution relative to baseline is\n$$\nq_{X} \\int_{t_{X}}^{t_{X}+d_{X}} \\left(u_{X}^{\\text{down}} - u_{X}^{\\text{base}}\\right) \\exp(-\\lambda t) \\, dt = q_{X} \\left(u_{X}^{\\text{down}} - u_{X}^{\\text{base}}\\right) \\frac{\\exp(-\\lambda t_{X}) - \\exp\\left(-\\lambda (t_{X} + d_{X})\\right)}{\\lambda}.\n$$\n\nTherefore, the expected QALMs for strategy $X$ is\n$$\nU_{X} = \\frac{u_{X}^{\\text{base}}}{\\lambda} + p_{X} \\left(u_{X}^{\\text{comp}} - u_{X}^{\\text{base}}\\right) \\frac{1 - \\exp(-\\lambda \\delta_{X})}{\\lambda} + q_{X} \\left(u_{X}^{\\text{down}} - u_{X}^{\\text{base}}\\right) \\frac{\\exp(-\\lambda t_{X}) - \\exp\\left(-\\lambda (t_{X} + d_{X})\\right)}{\\lambda}.\n$$\n\nApply to SEMS using the provided parameters:\n- $\\lambda = \\frac{\\ln(2)}{5}$.\n- $u_{S}^{\\text{base}} = 0.8$, $p_{S} = 0.15$, $u_{S}^{\\text{comp}} = 0.3$, $\\delta_{S} = 0.5$.\n- $q_{S} = 0.4$, $t_{S} = 2.5$, $d_{S} = 0.25$, $u_{S}^{\\text{down}} = 0.2$.\n\nCompute the exponentials using $\\lambda = \\frac{\\ln(2)}{5}$:\n$$\n\\exp(-\\lambda \\delta_{S}) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 0.5\\right) = 2^{-0.1} \\approx 0.9330329915368074,\n$$\n$$\n\\exp(-\\lambda t_{S}) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 2.5\\right) = 2^{-0.5} \\approx 0.7071067811865476,\n$$\n$$\n\\exp\\!\\left(-\\lambda (t_{S} + d_{S})\\right) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 2.75\\right) = 2^{-0.55} \\approx 0.683021.\n$$\nInsert into $U_{S}$:\n$$\nU_{S} = \\frac{0.8}{\\lambda} + 0.15 \\cdot (0.3 - 0.8) \\cdot \\frac{1 - 2^{-0.1}}{\\lambda} + 0.4 \\cdot (0.2 - 0.8) \\cdot \\frac{2^{-0.5} - 2^{-0.55}}{\\lambda}.\n$$\nSimplify coefficients:\n$$\nU_{S} = \\frac{1}{\\lambda}\\left[0.8 - 0.075\\,(1 - 2^{-0.1}) - 0.24\\,(2^{-0.5} - 2^{-0.55})\\right].\n$$\nNumerically,\n$$\n1 - 2^{-0.1} \\approx 0.0669670084631926,\\quad 2^{-0.5} - 2^{-0.55} \\approx 0.02408548,\n$$\nso\n$$\n\\text{bracket}_{S} \\equiv 0.8 - 0.075(1 - 2^{-0.1}) - 0.24(2^{-0.5} - 2^{-0.55}) \\approx 0.78919696,\n$$\nand since $\\frac{1}{\\lambda} = \\frac{5}{\\ln(2)} \\approx 7.213475204444817$,\n$$\nU_{S} \\approx 7.213475204444817 \\times 0.78919696 \\approx 5.6929 \\text{ QALMs}.\n$$\n\nApply to GJ using the provided parameters:\n- $u_{B}^{\\text{base}} = 0.75$, $p_{B} = 0.25$, $u_{B}^{\\text{comp}} = 0.2$, $\\delta_{B} = 1.0$.\n- $q_{B} = 0.1$, $t_{B} = 4.0$, $d_{B} = 0.5$, $u_{B}^{\\text{down}} = 0.2$.\n\nCompute the exponentials:\n$$\n\\exp(-\\lambda \\delta_{B}) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 1.0\\right) = 2^{-0.2} \\approx 0.870550563296124,\n$$\n$$\n\\exp(-\\lambda t_{B}) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 4.0\\right) = 2^{-0.8} \\approx 0.5743491774985174,\n$$\n$$\n\\exp\\!\\left(-\\lambda (t_{B} + d_{B})\\right) = \\exp\\!\\left(-\\tfrac{\\ln(2)}{5} \\cdot 4.5\\right) = 2^{-0.9} \\approx 0.535886731536.\n$$\nInsert into $U_{B}$:\n$$\nU_{B} = \\frac{0.75}{\\lambda} + 0.25 \\cdot (0.2 - 0.75) \\cdot \\frac{1 - 2^{-0.2}}{\\lambda} + 0.1 \\cdot (0.2 - 0.75) \\cdot \\frac{2^{-0.8} - 2^{-0.9}}{\\lambda}.\n$$\nSimplify coefficients:\n$$\nU_{B} = \\frac{1}{\\lambda}\\left[0.75 - 0.1375\\,(1 - 2^{-0.2}) - 0.055\\,(2^{-0.8} - 2^{-0.9})\\right].\n$$\nNumerically,\n$$\n1 - 2^{-0.2} \\approx 0.129449436703876,\\quad 2^{-0.8} - 2^{-0.9} \\approx 0.0384624459625,\n$$\nso\n$$\n\\text{bracket}_{B} \\equiv 0.75 - 0.1375(1 - 2^{-0.2}) - 0.055(2^{-0.8} - 2^{-0.9}) \\approx 0.73008527,\n$$\nand thus\n$$\nU_{B} \\approx 7.213475204444817 \\times 0.73008527 \\approx 5.2665 \\text{ QALMs}.\n$$\n\nFinally, compute the expected utility difference:\n$$\n\\Delta U = U_{\\text{SEMS}} - U_{\\text{GJ}} \\approx 5.6929 - 5.2665 \\approx 0.4264 \\text{ QALMs}.\n$$\nRounded to four significant figures, $\\Delta U \\approx 0.4264$ QALMs.",
            "answer": "$$\\boxed{0.4264}$$"
        }
    ]
}